GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Percheron Therapeutics Ltd (ASX:PER) » Definitions » Net Investment Income

Percheron Therapeutics (ASX:PER) Net Investment Income


View and export this data going back to 2001. Start your Free Trial

What is Percheron Therapeutics Net Investment Income?

Net Investment Income only applies to insurance companies.


Percheron Therapeutics (ASX:PER) Business Description

Traded in Other Exchanges
Address
14 Wallace Avenue, Toorak, VIC, AUS, 3142
Antisense Therapeutics Ltd is a drug manufacturer. The company is engaged in research and development of novel antisense pharmaceuticals. The company operates in two segments that have been identified based on its antisense oligonucleotide products as ATL1102 and ATL1103.